Anika Therapeutics buy Barrington Research
Start price
09.05.24
/
50%
€23.40
Target price
09.05.25
€34.32
Performance (%)
-5.98%
Price
27.09.24
€22.00
Summary
This prediction is currently active. With a performance of -5.98%, the BUY prediction for Anika Therapeutics by Barrington_Research is down slightly. This prediction currently runs until 09.05.25. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Anika Therapeutics | -3.509% | -3.509% |
iShares Core DAX® | 1.518% | 3.456% |
iShares Nasdaq 100 | 1.240% | 2.983% |
iShares Nikkei 225® | 2.808% | 2.743% |
iShares S&P 500 | 0.403% | 2.187% |
Comments by Barrington_Research for this prediction
In the thread Anika Therapeutics diskutieren
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.
Ratings data for ANIK provided by MarketBeat
Stopped prediction by Barrington_Research for Anika Therapeutics
Anika Therapeutics
Start price
Target price
Perf. (%)
€20.60
03.01.24
03.01.24
€26.58
03.01.25
03.01.25
6.80%
27.09.24
27.09.24
Anika Therapeutics
Start price
Target price
Perf. (%)
€19.70
03.11.23
03.11.23
€26.08
03.11.24
03.11.24
11.68%
27.09.24
27.09.24